Mast Therapeutics CEO Robert Neville's 2018 pay jumps 586% to $4.1M

Mast Therapeutics reports 2018 executive compensation

Published: April 15, 2019

Mast Therapeutics reported fiscal year 2018 executive compensation information on April 15, 2019.

In 2018, three executives at Mast Therapeutics received on average a compensation package of $3.4M, a 374% increase compared to previous year.

Average pay of disclosed executives at Mast Therapeutics

Robert Neville, Chief Executive Officer, received $4.1M in total, which increased by 586% compared to 2017. 81.22% of Neville's compensation, or $3.3M, was in option awards. Neville also received $225.8K in non-equity incentive plan, $525K in salary, as well as $22K in other compensation.

For fiscal year 2018, the median employee pay was $282,179 at Mast Therapeutics. Therefore, the ratio of Robert Neville's pay to the median employee pay was 15 to one.

Taneli Jouhikainen, Chief Operating Officer, received a compensation package of $3.9M, which increased by 547% compared to previous year. 80.67% of the compensation package, or $3.1M, was in option awards.

Dave Lowrance, Chief Financial Officer, earned $2.2M in 2018, a 459% increase compared to previous year.